Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William Nguyen who wrote ()	10/8/1998 5:25:00 PM
From: mesaone	Read Replies (1) of 1432

I was on the abbott conference call today. at the end a broker asked abt about biotime. He asked them to comment on the market size for Hextend. This was their reply: It's hard for us to say at this time. It depends upon the indications. It could be 40 or 50 million to $300 to $400 million. It's difficult for us to make any predictions at this time until we see what the label looks like. We think that this could be a nice modest contributor for us. the broker then asked if the fda's warning against using albumin would affect hextend's revenues, and abt said (quite positively) "It certainly helps"

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next